Dr Kneeland Youngblood - Jun 5, 2025 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Stock symbol
LNW
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:26 PM
Previous filing
Jun 10, 2024
Next filing
Jun 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
YOUNGBLOOD DR KNEELAND Director C/O LIGHT & WONDER, INC., 6601 BERMUDA ROAD, LAS VEGAS /s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood 2025-06-06 0001137820

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNW Common Stock Options Exercise $0 +2.16K +8.3% $0.00 28.2K Jun 5, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Options Exercise $0 -2.16K -100% $0.00 0 Jun 5, 2025 Common Stock 2.16K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of restricted stock units granted on June 5, 2024. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis.